Jeffrey Cleland

Doer
DISC Type : sd

Chairman, CEO & President at Ashvattha Therapeutics, Inc.

San Francisco Bay Area, United States

Overview

Jeffrey Cleland is the Chairman, CEO, and President of Ashvattha Therapeutics, a company he co-founded. With a Ph. D. from MIT, he has over 30 years of experience in the biotech industry, specializing in nanomedicine and successfully raising over $500 million in capital throughout his career.

Outside of his professional work, Jeffrey is dedicated to his community and family. He founded and previously chaired the Nativity School Development Fund to manage fundraising for the school and has publicly shared his pride in his daughters accomplishments and work in helping others.

He led one of the most successful biotech IPOs of all time based on valuation, demand, and total proceeds.

Personality Overview

Risk-Accepting

Fast-paced

Deliberate Doer

Reading between the lines and seeing beyond your words comes naturally to them.  They exhibit a rare combination of being result-oriented but patient at the same time. They might take some time to make their mind up but once they do, they don't change it easily.

Topics They Care About

Nanomedicine Development
He co-founded Ashvattha Therapeutics to develop novel nanomedicines, specifically hydroxyl dendrimer therapeutics, to treat inflammatory diseases, and often speaks on the topic.
Ophthalmology Treatments
Actively building his company's ophthalmology team to create at-home subcutaneous treatments for conditions like DME and AMD, aiming to replace more invasive methods.
Biotech Fundraising
Has extensive experience securing capital, having raised over $400 million as a CEO and leading one of the top biotech IPOs in history.

Media Appearances

Jeffrey has no verified media appearances

Work History

9-2019
Chairman, CEO & President at Ashvattha Therapeutics, Inc.
1-2023
Board Member at Elixirgen Therapeutics, Inc.
10-2022
Board Member at Syncromune®
9-2014
Member, Governing Board at Biotechnology Innovation Organization
9-2012
Board Member / Founder Nativity School Development Fund at Nativity Catholic School

Education

1986 - 1991
Ph.D. from Massachusetts Institute of Technology
9-1982 - 6-1986
B.S. from University of California, Davis

More Information

Social Presence :

Prographics :

Exp : 13 Location : San Francisco Bay Area, United States Job Level : Leadership Designation : Chairman, CEO & President at Ashvattha Therapeutics, Inc.
URL has been copied!

Insights For Selling To Jeffrey

During A Call Or A Meeting

DO's

  • Let them know of potential risks but suggest mitigation methods alongside
  • Suggest clear next steps with confidence, don't be vague or hesitant
  • Focus on the results that your product produces, expect some strategic questions in return

DONT's

  • Avoid putting conscious effort into relationship-building
  • Don't focus too much on mutual contacts or bother about other stakeholders, focus on them
  • Don't take their patience for granted, avoid long-winding sermons

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jeffrey is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Jeffrey

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Jeffrey move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Jeffrey take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Jeffrey

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.